These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9667114)

  • 41. Trimethoprim-sulfamethoxazole-induced hypoglycemia.
    Fox GN
    J Am Board Fam Pract; 2000; 13(5):386. PubMed ID: 11001017
    [No Abstract]   [Full Text] [Related]  

  • 42. Hyperkalemia and trimethoprim-sulfamethoxazole.
    Postelnick M; Budris W; Noskin GA
    Ann Intern Med; 1996 Nov; 125(9):778; author reply 779-80. PubMed ID: 8929017
    [No Abstract]   [Full Text] [Related]  

  • 43. Acute pancreatitis. A fatal complication of AIDS therapy.
    Aboulafia DM
    J Clin Gastroenterol; 1997 Dec; 25(4):640-5. PubMed ID: 9451679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome.
    Walker DC; Cohen PR
    J Am Acad Dermatol; 1996 May; 34(5 Pt 2):918-23. PubMed ID: 8621829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patch testing in an unusual case of toxic epidermal necrolysis.
    Klein CE; Trautmann A; Zillikens D; Bröcker EB
    Contact Dermatitis; 1996 Sep; 35(3):175-6. PubMed ID: 8930481
    [No Abstract]   [Full Text] [Related]  

  • 46. Hyperkalemia and trimethoprim-sulfamethoxazole.
    Parker MG
    Ann Intern Med; 1996 Nov; 125(9):778-9; author reply 779-80. PubMed ID: 8929020
    [No Abstract]   [Full Text] [Related]  

  • 47. Immune response to sulfamethoxazole in patients with AIDS.
    Daftarian MP; Filion LG; Cameron W; Conway B; Roy R; Tropper F; Diaz-Mitoma F
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):199-204. PubMed ID: 7697529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection.
    Wong YY; Rakasz EG; Gasper DJ; Friedrich TC; Trepanier LA
    Toxicology; 2016 Aug; 368-369():10-18. PubMed ID: 27565715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem?
    Alappan R; Buller GK; Perazella MA
    Am J Nephrol; 1999; 19(3):389-94. PubMed ID: 10393376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Side effects of trimethoprim-sulfamethoxazole in patients with AIDS].
    Weinke T; Sixt C; de Matos-Marques B; Ruf B; Pohle HD
    Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1129-33. PubMed ID: 3260553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Drug hypersensitivity in AIDS patients: report of a case].
    Ribeiro LM; Pastorino AC; Grumach AS; Jacob CM
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(1):23-7. PubMed ID: 9334468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful treatment of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in hypersensitive AIDS patients.
    Gibbons RB; Lindauer JA
    JAMA; 1985 Mar; 253(9):1259-60. PubMed ID: 3871490
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hyperkalemia induced by high-dose trimethoprim].
    Rispal P; Lasseur C; Pellegrin JL; Leng B
    Presse Med; 1995 Dec; 24(37):1754. PubMed ID: 8545422
    [No Abstract]   [Full Text] [Related]  

  • 54. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children.
    Palusci VJ; Kaul A; Lawrence RM; Haines KA; Kwittken PL
    Pediatr Infect Dis J; 1996 May; 15(5):456-60. PubMed ID: 8724071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The acquired immunodeficiency syndrome and a trimethoprim-sulfamethoxazole adverse reaction.
    Cohn DL; Penley KA; Judson FN; Kirkpatrick CH; Horsburgh CR; Davis KC
    Ann Intern Med; 1984 Feb; 100(2):311. PubMed ID: 6607009
    [No Abstract]   [Full Text] [Related]  

  • 56. Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity.
    O'Neil WM; MacArthur RD; Farrough MJ; Doll MA; Fretland AJ; Hein DW; Crane LR; Svensson CK
    J Clin Pharmacol; 2002 Jun; 42(6):613-9. PubMed ID: 12043950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trimethoprim/sulfamethoxazole induced multiorgan dysfunction.
    Lee JS; Owshalimpur D; Schofield C
    BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23257644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trimethoprim is a potassium-sparing diuretic like amiloride and causes hyperkalemia in high-risk patients.
    Perazella MA
    Am J Ther; 1997; 4(9-10):343-8. PubMed ID: 10423629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.
    Piketty C; Gilquin J; Kazatchkine MD
    J Infect Dis; 1995 Aug; 172(2):611. PubMed ID: 7622921
    [No Abstract]   [Full Text] [Related]  

  • 60. Successful desensitization in a child with delayed cotrimoxazole hypersensitivity: A case report.
    D'Amelio CM; Del Pozo JL; Vega O; Madamba R; Gastaminza G
    Pediatr Allergy Immunol; 2016 May; 27(3):320-1. PubMed ID: 26660294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.